Latest News

COVID-19 Prompts 'Lifesaving' Policy Change for Opioid Addiction

In the face of COVID-19, SAMHSA has announced policy changes that will allow some patients in treatment for opioid use disorder to receive a 28-day take-home supply of medication.

Source link

Related posts

BIOTRONIK’s Single Lead, Dual Chamber Acticor ICDs and CRT-Ds Coming to U.S.


EGS receives $30.5M to advance minimally invasive GERD Technique


Novel tissue engineering scaffolds fabricated via controlled ice crystallization…


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World